Quest Diagnostics Inc
(DGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 73,302 | 154,958 | 96,777 | 122,332 | 171,477 |
| Receivables | 649,281 | 609,187 | 522,131 | 508,340 | 485,573 |
| Inventories | 75,327 | 72,484 | 60,899 | 49,906 | 44,274 |
| Income taxes - deferred | 83,030 | 108,975 | 102,700 | 157,649 | 188,483 |
| TOTAL | $931,080 | $995,786 | $824,443 | $876,514 | $980,689 |
| Non-Current Assets | |||||
| PPE Net | 619,485 | 607,305 | 570,149 | 508,619 | 449,856 |
| Intangibles | 2,518,412 | 2,535,853 | 1,810,933 | 1,379,143 | 1,261,603 |
| Other Non-Current Assets | 134,811 | 162,474 | 118,672 | 166,279 | 172,388 |
| TOTAL | $3,272,708 | $3,305,632 | $2,499,754 | $2,054,041 | $1,883,847 |
| Total Assets | $4,203,788 | $4,301,418 | $3,324,197 | $2,930,555 | $2,864,536 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 374,801 | 73,950 | 26,032 | 1,404 | 265,408 |
| Accounts payable and accrued liabilities | 668,987 | 649,850 | 609,945 | 657,219 | 689,582 |
| TOTAL | $1,043,788 | $723,800 | $635,977 | $658,623 | $954,990 |
| Non-Current Liabilities | |||||
| Long Term Debt | 724,021 | 1,028,707 | 796,507 | 820,337 | 760,705 |
| Other Non-Current Liabilities | 147,328 | 154,217 | 122,850 | 115,608 | 117,046 |
| TOTAL | $871,349 | $1,182,924 | $919,357 | $935,945 | $877,751 |
| Total Liabilities | $1,915,137 | $1,906,724 | $1,555,334 | $1,594,568 | $1,832,741 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 202,846 | 207,209 | 210,362 | 192,586 | N/A |
| Common Shares | 1,068 | 1,068 | 980 | 960 | 465 |
| Retained earnings | 818,734 | 380,559 | -40,772 | -362,926 | -525,111 |
| Other shareholders' equity | 3,503 | 4,053 | -8,856 | -16,723 | -36,535 |
| TOTAL | $2,288,651 | $2,394,694 | $1,768,863 | $1,335,987 | $1,031,795 |
| Total Liabilities And Equity | $4,203,788 | $4,301,418 | $3,324,197 | $2,930,555 | $2,864,536 |